Improving AAV and LV Upstream GMP Manufacturing
The data in this poster demonstrate that VirusGEN® pushes the limits of high titer recombinant AAV and LV production to provide more usable virus per run, maximizing precious time and resources.
Please complete the form below to download this poster. Thank you for your interest!
Like this paper? We have more content like it!
Visit our blog: The TransMission
Or, sign up for our Transfection Connection newsletter below!